Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Colorectal Cancer
- Sponsor
- Renmin Hospital of Wuhan University
- Enrollment
- 1000
- Locations
- 1
- Primary Endpoint
- Confirmation of diagnosis by pathologist
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.
Investigators
Tao Fu
Director of Department of GI Surgery II
Renmin Hospital of Wuhan University
Eligibility Criteria
Inclusion Criteria
- •Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery.
- •Must be willing and able to provide informed consent.
Exclusion Criteria
- •Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.
Outcomes
Primary Outcomes
Confirmation of diagnosis by pathologist
Time Frame: Up to 3 years
Once tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.